Medical Devices
HOPE Therapeutics Launches Revolutionary One-Day Depression Treatment Protocol in Florida
NRx Pharmaceuticals' subsidiary HOPE Therapeutics has initiated Florida's first deployment of a rapid one-day TMS protocol for treatment-resistant depression, potentially transforming care for millions suffering from depression and PTSD.
Houston Medical Technology Company Wins Global Health Tech Competition for Pediatric Heart Innovation
PolyVascular's victory in the American Heart Association's Health Tech Competition highlights a breakthrough minimally invasive valve technology that could transform care for children with congenital heart disease by reducing the need for repeated open-heart surgeries.
Wireless Brain Implants Could Revolutionize Neurological Treatment Without Surgery
MIT researchers have developed microscopic wireless implants that can navigate to brain tissue autonomously, potentially eliminating the need for surgery in treating tumors and neurological conditions.
Olympus Announces Major Restructuring Strategy to Transform Endoscopy Care Through AI and Robotics
Olympus Corporation unveiled a comprehensive corporate strategy focused on advancing AI-powered endoscopy and robotics while implementing significant workforce reductions and organizational changes to drive innovation in medical technology.
HeartBeam Submits Breakthrough ECG Technology for FDA Clearance
HeartBeam Inc. has submitted its innovative 12-lead ECG synthesis software to the FDA for clearance, representing a significant advancement in cardiac arrhythmia detection and management.
Sigyn Therapeutics Advances CardioDialysis™ to Address Cardiovascular Disease in Dialysis Patients
Sigyn Therapeutics is developing CardioDialysis™, a medical device that leverages existing dialysis infrastructure to treat cardiovascular disease in end-stage renal disease patients, who face a 67% mortality rate from heart conditions and limited benefit from traditional drug therapies.
HeartBeam Receives Buy Rating and $4 Price Target from Roth Capital, Highlighting FDA Clearance Catalyst
HeartBeam Inc. received a Buy rating and $4 price target from Roth Capital, which emphasized the company's potential FDA clearance for its 12-lead ECG synthesis software and its position to transform remote cardiac monitoring.
Ocumetics Reports Promising Early Results in First Human Lens Implant Study
Ocumetics Technology Corp. announced encouraging one-month vision results from its first human clinical study of an accommodating intraocular lens, showing potential to transform cataract treatment and reduce dependence on corrective lenses.
NeuroOne Granted 180-Day Extension to Regain Nasdaq Compliance
NeuroOne Medical Technologies has received an additional 180 days to meet Nasdaq's minimum bid price requirement, providing crucial breathing room for the neurological device company to stabilize its stock performance and avoid potential delisting.
LogicMark CEO Discusses Connected Care Platform for At-Risk Populations
LogicMark CEO Chia-Lin Simmons detailed the company's comprehensive medical safety device offerings for seniors across all care levels during a recent interview, highlighting the importance of connected care technology for vulnerable populations.
AI Tool Detects Structural Heart Disease Using Smartwatch ECG Sensors
An artificial intelligence algorithm paired with smartwatch ECG sensors can accurately detect structural heart diseases, potentially making early screening more accessible to millions of people who already own these devices.
HeartBeam to Discuss Q3 2025 Results and Regulatory Progress in November Conference Call
HeartBeam will host a conference call on November 13, 2025, to discuss third-quarter results and provide updates on its FDA-cleared 3D ECG technology that could transform remote cardiac monitoring.
Olympus Launches Combined Imaging Mode to Enhance Cancer Detection Capabilities
Olympus Corporation has introduced a new NBI+TXI observation mode for its EVIS X1 endoscopy system that combines two advanced imaging technologies to improve detection and diagnostic accuracy for gastrointestinal and respiratory cancers, addressing Japan's high cancer incidence rates.
FDA Clears First 4-in-1 Home Test for RSV, Flu, and COVID Detection
ACON Laboratories has received FDA clearance for the first over-the-counter home test that simultaneously detects RSV, influenza A, influenza B, and COVID-19, representing a significant advancement in consumer respiratory health monitoring.
PetVivo Holdings to Showcase Veterinary Medical Innovations at Spartan Capital Investor Conference
PetVivo Holdings will present its innovative veterinary medical devices at the Spartan Capital Securities investor conference, highlighting the company's growth potential in the animal healthcare market.
New LED Therapy Shows Promise in Targeting Cancer Cells While Preserving Healthy Tissues
Researchers have developed a novel LED-based cancer treatment that selectively destroys cancer cells while minimizing damage to healthy tissues, potentially offering a more precise alternative to conventional therapies like chemotherapy and radiation.
Nutriband's AVERSA Fentanyl Patch Advances Toward 2026 FDA Submission with $200M Market Potential
Nutriband Inc. is progressing with its abuse-deterrent fentanyl patch technology that could generate up to $800 million in annual sales while addressing the opioid crisis through tamper-resistant transdermal delivery.
Ovation Med Spa Introduces Advanced Body Contouring Technology to Address Growing Demand
Ovation Med Spa's launch of BodyEstiq™ Onda Coolwaves® technology represents a significant advancement in non-invasive body contouring that addresses increasing consumer demand for effective fat reduction, cellulite treatment, and skin tightening solutions.
Izotropic Corporation Outlines Commercialization Strategy for IzoView Breast CT Platform
Izotropic Corporation's CEO details the company's 12-18 month commercialization plan for its breast CT imaging technology, including FDA clinical studies and European market expansion, which could significantly improve breast cancer detection and treatment.
AXIM Biotechnologies Secures Exclusive South Korean Distribution for TearScan Diagnostic Tests
AXIM Biotechnologies has partnered with VisionPlus Corp. to exclusively distribute its TearScan diagnostic tests in South Korea, expanding access to advanced ocular diagnostics in a market experiencing rising dry eye disease cases.
Patented Laonson Pill Cutter Launches Globally on Kickstarter with Automatic Center-Aligning Technology
The Laonson Pill Cutter introduces patented automatic center-aligning technology that ensures precise medication division, addressing a critical healthcare need for accurate dosing across personal and professional settings.
Danaher Exceeds Expectations with Strong Third Quarter 2025 Performance
Danaher Corporation reported better-than-expected third quarter 2025 results with 4.5% revenue growth and strong cash flow generation, driven by bioprocessing momentum and respiratory revenue at Cepheid, demonstrating the company's resilience in the healthcare sector.
Blackstone and TPG Near $17 Billion Acquisition of Hologic in Major Healthcare Buyout
Private equity firms Blackstone and TPG are finalizing a $17 billion acquisition of women's health company Hologic, signaling renewed investor confidence in healthcare assets with stable revenue streams.
HeartBeam's Portable ECG Technology Poised to Transform Cardiac Care with Medical-Grade Accuracy
HeartBeam is advancing a portable, credit-card-sized device that captures three-dimensional heart signals and reconstructs them into synthesized 12-lead ECGs, potentially enabling earlier detection of heart rhythm problems and reducing hospitalizations through accessible, patient-centered cardiac monitoring.
Innovation Emerges as Critical Driver for Next Generation Medical Technology
Medical technology innovation is transforming healthcare delivery through improved diagnostics, personalized treatments, and enhanced efficiency while addressing emerging challenges in patient care.
HeartBeam's Portable ECG Technology Poised to Transform Cardiac Care Delivery
HeartBeam Inc. is advancing a portable, credit-card-sized device that captures three-dimensional heart signals and reconstructs them into full 12-lead ECGs, potentially enabling earlier detection and treatment of heart conditions outside medical facilities.
NeuroOne Expands Executive Leadership with Promotion of Emily Johns to Chief Administrative Officer
NeuroOne Medical Technologies has promoted Emily Johns to Chief Administrative Officer, signaling strategic focus on operational infrastructure as the company scales its neurological disorder treatment technologies.
Humacyte Secures $60 Million in Oversubscribed Stock Offering to Advance Bioengineered Tissue Platform
Humacyte's successful $60 million capital raise provides critical funding to accelerate development of its universally implantable bioengineered human tissues, which have received multiple FDA designations and could transform treatment for vascular trauma, dialysis access, and other medical conditions.
FDA Approves One-Minute HIV Self-Test in Major Public Health Advancement
The FDA's approval of bioLytical's INSTI® HIV Self Test, which provides results in 60 seconds, represents a significant step toward reducing undiagnosed HIV cases and supporting national goals to end the HIV epidemic by making testing more accessible and private.
NeuroOne Expands Global Patent Portfolio with Key Approvals for Neurological Technology
NeuroOne Medical Technologies has strengthened its intellectual property position with new patent approvals in the US and Europe, signaling expanded opportunities for its neurological disorder treatment technologies.